Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperparathyroidism, Secondary”

272 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 272 results

Large-scale testing (Phase 3)Ended earlyNCT04064827
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)

Who this might be right for
Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
AbbVie 2
Post-approval studies (Phase 4)Study completedNCT02056730
What this trial is testing

The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid

Who this might be right for
Hyperparathyroidism, Secondary
Chulalongkorn University 60
Not applicableStudy completedNCT04267965
What this trial is testing

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Who this might be right for
Secondary Hyperparathyroidism Due to Renal Causes
Chang Gung Memorial Hospital 48
Post-approval studies (Phase 4)Study completedNCT00803712
What this trial is testing

20070360 Incident Dialysis

Who this might be right for
Chronic Kidney DiseaseSecondary Hyperparathyroidism
Amgen 313
Large-scale testing (Phase 3)Study completedNCT05836220
What this trial is testing

Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2

Who this might be right for
Secondary HyperparathyroidismEnd Stage Kidney Disease
Pathalys Pharma 412
Post-approval studies (Phase 4)Study completedNCT00454350
What this trial is testing

Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Who this might be right for
Secondary Hyperparathyroidism
Genzyme, a Sanofi Company 12
Testing effectiveness (Phase 2)Study completedNCT00508885
What this trial is testing

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

Who this might be right for
Hyperphosphatemia
Washington University School of Medicine 17
Not applicableLooking for participantsNCT07141043
What this trial is testing

Assessment of Mineral and Bone Disorders in Kidney Transplant Recipients

Who this might be right for
HemodyalysisKidney TansplantOsteoporosis+1 more
Grigore T. Popa University of Medicine and Pharmacy 180
Testing effectiveness (Phase 2)Study completedNCT01254565
What this trial is testing

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism
KAI Pharmaceuticals 87
Testing effectiveness (Phase 2)Study completedNCT00560300
What this trial is testing

Regulation of Bone Formation in Renal Osteodystrophy

Who this might be right for
Secondary HyperparathyroidismRenal Osteodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 61
Testing effectiveness (Phase 2)Study completedNCT01220050
What this trial is testing

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism

Who this might be right for
Renal TransplantSecondary Hyperparathyroidism
Mario Negri Institute for Pharmacological Research 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07654231
What this trial is testing

Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD

Who this might be right for
Chronic Kidney Disease Mineral and Bone DisorderHypertensionDiabetes+3 more
University of Texas Southwestern Medical Center 60
Large-scale testing (Phase 3)Looking for participantsNCT07122401
What this trial is testing

Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism

Who this might be right for
Secondary Hyperparathyroidism, Chronic Kidney Disease
Shaanxi Micot Pharmaceutical Technology Co., Ltd. 424
Early research (Phase 1)Study completedNCT02833857
What this trial is testing

A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis

Who this might be right for
Chronic Kidney Disease, Secondary Hyperparathyroidism
Amgen 11
Not applicableStudy completedNCT00587158
What this trial is testing

Oral Paricalcitol in Kidney Transplant Recipients

Who this might be right for
Transplant; Failure, KidneyRenal Disease, End StageHyperparathyroidism, Secondary
Mayo Clinic 100
Post-approval studies (Phase 4)Study completedNCT01573520
What this trial is testing

Treatment Adhesion in Dialysis Patients Treated With Cinacalcet

Who this might be right for
HyperparathyroidismChronic Kidney Disease
Michel Burnier 50
Post-approval studies (Phase 4)Study completedNCT00958451
What this trial is testing

Vitamin D Deficiency in Chronic Kidney Disease (CKD) Patients

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Salem Veterans Affairs Medical Center 80
Large-scale testing (Phase 3)Study completedNCT00345839
What this trial is testing

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

Who this might be right for
Secondary HyperparathyroidismChronic Kidney Disease
Amgen 3,883
Testing effectiveness (Phase 2)WithdrawnNCT01665651
What this trial is testing

Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy

Who this might be right for
Renal Insufficiency, ChronicRenal Osteodystrophy
Bing Shu
Not applicableStudy completedNCT00785629
What this trial is testing

A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD

Who this might be right for
Chronic Kidney Disease
Denver Nephrologists, P.C. 148
Next Page